Vitrafy Life Sciences Limited (ASX:VFY)

Vitrafy Life Sciences Revenue

Vitrafy Life Sciences had revenue of 1.98M AUD in the half year ending December 31, 2025, with 64.59% growth. This brings the company's revenue in the last twelve months to 2.34M, up 51.87% year-over-year. In the fiscal year ending June 30, 2025, Vitrafy Life Sciences had annual revenue of 1.05M, down -49.14%.

• Revenue (ttm): 2.34M
• Revenue Growth: +51.87%
• P/S Ratio: 78.75
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 184.53M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	1.05M	-1.01M	-49.14%
Jun 30, 2024	2.06M	3.53K	0.17%
Jun 30, 2023	2.06M	230.64K	12.63%
Jun 30, 2022	1.83M	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 30, 2026

Data Sources Report a data error